NIH-funded research R01 grant

Understanding how DNA damage leads to mutations in human tissues

Official title: Davoli/Mita Diversity Supplement

Funded at New York University School of Medicine · NIH-11090156 · Data updated 2026-11-12

This study is looking at how our genes can change and cause problems in our cells, especially in cancer cells, and it's testing a new tool to see how often these changes happen, which could help us understand more about diseases like cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 15, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$124,979
NIH project number3R01HG012590-02S1
Project IDNIH-11090156 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of cancer or those at high risk for developing cancer due to genetic or environmental factors.

Less likely to help

Patients with conditions unrelated to DNA damage or mutation processes may not benefit from this research.

What this research studies

This research investigates the genetic causes of mutations in human tissues and how different cell types manage DNA damage and repair. By developing a novel tool called MutSensor, the researchers aim to measure DNA mutation frequency in mammalian cells with unprecedented sensitivity. The study will utilize advanced genetic techniques to identify genes that influence mutation rates in various human cell types, including cancer cells. This comprehensive approach seeks to deepen our understanding of how mutations contribute to diseases like cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing and treating cancer by targeting the mechanisms of DNA damage and repair.

How similar studies have gone: Other research has shown success in understanding DNA damage and repair mechanisms, but this approach using MutSensor is innovative and aims to provide new insights.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Davoli, Teresa — New York University School of Medicine
  • Study coordinator: Davoli, Teresa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.